ORGO
Organogenesis Holdings Inc
NASDAQ: ORGO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.35
+2.17% today
Updated 2026-04-30
Market cap
$307.45M
P/E ratio
15.93
P/S ratio
0.55x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$2 – $7
Volume
1.4M
Organogenesis Holdings Inc (ORGO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |